New mechanism for unleashing immune system against cancer discovered
Monday, April 7, 2014 - 15:02
in Health & Medicine
A major discovery brings a new drug target to the increasingly exciting landscape of cancer immunotherapy. The study is particularly noteworthy because it reveals a new way to block the function of CTLA-4, an immune inhibitory checkpoint receptor already generating huge interest in the pharmaceutical and research communities due to its potential in fighting cancer. An antibody that blocks CTLA-4 is already in use for advanced melanoma.